MedPath

EVEROLIMUS TAD 5 MG COMPRIMIDOS EFG

EVEROLIMUS TAD 5 MG COMPRIMIDOS EFG

Commercialized
Register Number

83527

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Oct 18, 2018

Dosage Form

COMPRIMIDO

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number83527
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

EVEROLIMUSActive
Quantity: 5 mg
Name: EVEROLIMUS

ATC CLASSIFICATION (3)

L01E
L01EG
L01EG02

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.